Advances in Chromobacterium violaceum and properties of violacein-Its main secondary metabolite: A review

Biotechnology Advances

Volumn 34, Issue 5, 2016, Pages 1030-1045

  Durán, Nelson ^a,b   Justo, Giselle Z ^c   Durán, Marcela ^a   Brocchi, Marcelo ^a   Cordi, Livia ^a   Tasic, Ljubica ^a   Castro, Guillermo R ^d   Nakazato, Gerson ^e  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Universidad Nacional de La Plata   (Argentina)

^e STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Anticancer; Antiparasitic; Antrimicrobial; Chromobacterium violaceum; Industrial applications; Violacein

Indexed keywords

BIOCHEMISTRY; INDUSTRIAL APPLICATIONS; INDUSTRIAL RESEARCH;

ANTICANCER; ANTIPARASITIC; ANTRIMICROBIAL; CHROMOBACTERIUM VIOLACEUM; VIOLACEIN;

METABOLITES;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOTECHNOLOGY; CANCER; INDUSTRIAL DEVELOPMENT; SECONDARY METABOLITE;

ALTEROMONAS; CHROMOBACTERIUM VIOLACEUM; COLLIMONAS; DUGANELLA; ESCHERICHIA; JANTHINOBACTERIUM; PSEUDOALTEROMONAS;

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; INDOLE DERIVATIVE; PIGMENT; VIOLACEIN;

ANIMAL; CHROMOBACTERIUM; HUMAN; MICROBIOLOGY; MOUSE; TUMOR CELL LINE;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHROMOBACTERIUM; HUMANS; INDOLES; INDUSTRIAL MICROBIOLOGY; MICE; PIGMENTS, BIOLOGICAL;

EID: 84993908970     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2016.06.003     Document Type: Review

References (168)

1. Ahmad, W.A., Yusof, N.Z., Nordin, N., Zakaria, Z.A., Rezali, M.F., Production and characterization of violacein by locally isolated Chromobacterium violaceum grown in agricultural wastes. Appl. Biochem. Biotechnol. 167 (2012), 1220–1234.
2. Ahmad, A., Viljoen, A.M., Chenia, H.Y., The impact of plant volatiles on bacterial quorum sensing. Lett. Appl. Microbiol. 60 (2014), 8–19.
3. Ahmetagic, A., Pemberton, J.M., Stable high level expression of the violacein indolocarbazole anti-tumour gene cluster and the Streptomyces lividans amy A gene in E. coli K12. Plasmid 63 (2010), 79–85.
4. Al-Hussaini, R., Mahasneh, A.M., Microbial growth and quorum sensing antagonist activities of herbal plants extracts. Molecules 14 (2009), 3425–3435.
5. Alkhalaf, L.M., Ryan, K., Biosynthetic manipulation of tryptophan in bacteria: pathways and mechanisms. Chem. Biol. 22 (2015), 317–328.
6. Ambily, R., Beena, A.K., Krishna, S.V., Detection of Chromobacterium violaceum in pasteurized milk samples from an organized dairy plant in Thrissu Kerala. Indian J. Appl. Res. 4 (2014), 420–421.
7. Andrighetti-Fröhner, C.R., Antonio, R.V., Creczynski-Pasa, T.B., Barardi, C.R.M., Simões, C.M.O., Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacterium violaceum. Mem. Inst. Oswaldo Cruz (Rio J.) 98 (2003), 843–848.
8. Antonisamy, P., Ignacimuthu, S., Immunomodulatory, analgesic and antipyretic effects of violacein isolated from Chromobacterium violaceum. Phytomedicine 17 (2010), 300–304.
9. Antonisamy, P., Kannan, P., Aravinthan, A., Duraipandiyan, V., Arasu, M.V., Ignacimuthu, S., et al. Gastroprotective activity of violacein isolated from Chromobacterium violaceum on indomethacin-induced gastric lesions in rats: investigation of potential mechanisms of action. Sci. World J., 2014, 2014, 616432.
10. Aranda, S., Montes-Borrego, M., Landa, B.B., Purple pigmented violacein-producing Duganella spp. inhabit the rhizosphere of wild and cultivated olives in Southern Spain. Microbial. Ecol. 62 (2011), 446–459.
11. Arosio, M., Raglio, A., Ruggeri, M., Ortega, P.S., Morali, L., De Angelis, C., et al. Chromobacterium violaceum lymphadenitis successfully treated in a Northern Italian hospital. New Microbiol. 34 (2011), 429–432.
12. Aruldass, C.A., Rubiyatno, Venil, C.K., Ahmad, W.A., Violet pigment production from liquid pineapple waste by Chromobacterium violaceum UTM5 and evaluation of its bioactivity. RSC Adv. 5 (2015), 51524–51536.
13. Asamizu, S., Kato, Y., Tgarashi, Y., Onaka, H., VioE, a prodeoxyviolacein synthase invilved in violacein biosynthesis, is responsible for intremolecular indole rearrangement. Tetrahedron Lett. 48 (2007), 2923–2926.
14. Asencio, G., Lavin, P., Alegría, K., Domínguez, M., Bello, H., González-Rocha, G., González-Aravena, M., et al. Antibacterial activity of the Antarctic bacterium Janthinobacterium sp. SMN 33.6 against multi-resistant Gram-negative bacteria. Electr. J. Biotechnol. 17 (2014), 1–5.
15. August, P.R., Grossman, T.H., Minor, C., Draper, M.P., MacNeil, I.A., Pemberton, J.M., et al. Sequence analysis and functional characterization of the violacein biosynthetic pathway from Chromobacterium violaceum. J. Mol. Microbiol. Biotechnol. 2 (2000), 513–519.
16. Avgustin, J.A., Bertok, D.Z., Kostanjsek, R., Avgustin, G., Isolation and characterization of a novel violacein-like pigment producing psychrotrophic bacterial species Janthinobacterium svalbardensis sp. Nov. Antonie van Leeuwenhoek Inter. J. Gen. Mol. Microbiol. 103 (2013), 763–769.
17. Bailly, J.D., Muller, C., Jaffrezou, J.P., Demur, C., Cassar, G., Bordier, C., et al. Lack of correlation between expression and function of p-glycoprotein in acute myeloid-leukemia cell-lines. Leukemia 9 (1995), 799–807.
18. Balibar, C.J., Walsh, C.T., In vitro biosynthesis of violacein from L-tryptophan by the enzymes VioA–E from Chromobacterium violaceum. Biochemistry 45 (2006), 15444–15457.
19. Baek, S.H., Kang, H.S., Jang, I.H., Lee, J.S., Kim, S.Y., Baek, J.H., et al. Insecticide and Fungicide Containing Violacein, and their Preparation Method. Repub Korean Kongkae Taeho Kongbo KR 2007088150 A. 2007.
20. Baldi, M., Morales, J.A., Hernandez, G., Jimenez, M., Alfaro, A., Barquero-Calvo, E., Chromobacterium violaceum infection in a free-ranging Howler monkey in Costa Rica. J. Wildlife Dis. 46 (2010), 306–310.
21. Ballestriero, F., Daim, M., Penesyan, A., Nappi, J., Schleheck, D., Bazzicalupo, P., et al. Antinematode activity of violacein and the role of the insulin/IGF-1 pathway in controlling violacein sensitivity in Caenorhabditis elegans. PLoS One, 9, 2014, e109201.
22. Becker, M.H., Brucker, R.M., Schwantes, C.R., Harris, R.N., Minbiole, K.P., The bacterially produced metabolite violacein is associated with survival of amphibians infected with a lethal fungus. Appl. Environ. Microbiol. 75 (2009), 6635–6638.
23. Berni, E., Marcato, P.D., Nakazato, G., Kobayashi, R.K.T., Vacchi, F.I., Umbuzeiro, G.A., et al. Violacein/poly(ε-caprolactone)/chitosan nanoparticles against bovine mastistis: antibacterial and ecotoxicity evaluation. J. Phys. Conf. Ser., 429, 2013, 012030.
24. Bottieau, E., Mukendi, D., Kalo, J.-R., Mpanya, A., Lutumba, P., Barbé, B., et al. Fatal Chromobacterium violaceum bacteraemia in rural Bandundu, Democratic Republic of the Congo. New Microbiol. New Infect. 3 (2015), 21–23.
25. Brazilian National Genome Project Consortium, The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability. Proc. Natl. Acad. U. S. A. 100 (2003), 11660–11665.
26. Brito, C.F., Carvalho, C.B., Gazzinelli, R.T., Oliveira, S.C., Azevedo, V., Teixeira, S.M., Chromobacterium violaceum genome: molecular mechanisms associated with pathogenicity. Genet. Mol. Res. 3 (2004), 148–161.
27. Bromberg, N., Dreyfuss, J.L., Regatieri, C.V., Palladino, M.V., Durán, N., Nader, H.B., et al. Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor. Chem. Biol. Interact. 186 (2010), 43–52.
28. Bromberg, N., Justo, G.Z., Haun, M., Durán, N., Ferreira, C.V., Violacein cytotoxicity on human blood lymphocytes and effect on phosphatases. J. Enzyme Inhib. Med. Chem. 20 (2005), 449–454.
29. Campbell, J.I., Lan, N.P.H., Qui, P.T., Dung, L.T., Farrar, J.J., Baker, S., A successful antimicrobial regime for Chromobacterium violaceum induced bacteremia. BMC Infect. Dis., 13, 2013, 4.
30. Castillo-Juárez, I., García-Contreras, R., Velázquez-Guadarrama, N., Soto-Hernández, M., Martínez-Vázquez, M., Amphypterygium adstringens anacardic acid mixture inhibits quorum sensing-controlled virulence factors of Chromobacterium violaceum and Pseudomonas aeruginosa. Arch. Med. Res. 44 (2013), 488–494.
31. Castro-Gomes, T., Cardoso, M.S., Da Rocha, W.D., Laibida, L.A., Nascimento, A.M.A., Zuccherato, L.W., et al. Identification of secreted virulence factors of Chromobacterium violaceum. J. Microbiol. 52 (2014), 350–353.
32. Cazoto, L.L., Martins, D., Ribeiro, M.G., Durán, N., Nakazato, G., Antibacterial activity of violacein against Staphylococcus aureus isolated from bovine mastitis. J. Antibiotics (Tokyo) 64 (2011), 395–397.
33. Chang, F.-Y., Ternei, M.A., Calle, P.Y., Brady, S.F., Discovery and synthetic refactoring of tryptophan dimer gene clusters from the environment. J. Am. Chem. Soc. 135 (2013), 17906–17912.
34. Chaudhari, V., Gosai, H., Raval, S., Kothari, V., Effect of certain natural products and organic solvents on quorum sensing in Chromobacterium violaceum. Asian Pac J Trop Med 7:Suppl. 1 (2014), S204–S211.
35. Chen, C.H., Lin, L.C., Liu, C.E., Young, T.C., Chromobacterium violaceum infection: a case report. J. Microbiol. Immunol. Infect. 36 (2003), 141–144.
36. Cheong, B.M.K., A fatal case of pulmonary Chromobacterium violaceum infection in an adult. Med. J. Malaysia 65 (2010), 148–149.
37. Choi, S.Y., Yoon, K.-H., Lee, J.L., Mitchell, R.J., Violacein: properties and production of a versatile bacterial pigment. BioMed. Res. Inter., 2015, 465056.
38. Choi, S.Y., Kim, S.B., Mitchell, R.J., High-level production of violacein by the newly isolated Duganella violaceinigra str. NI28 and its impact on Staphylococcus aureus. Sci. Rep., 5, 2015, 15598.
39. Chong, Y.M., Yin, W.F., Ho, C.Y., Mustafa, M.R., Hadi, A.H., Awang, K., et al. Malabaricone C from Myristica cinnamomea exhibits anti-quorum sensing activity. J. Nat. Prod. 74 (2011), 2261–2264.
40. Choo, J.H., Rukayadi, Y., Hwang, J.-K., Inhibition of bacterial quorum sensing by vanilla extract. Lett. Appl. Microbiol. 42 (2006), 637–641.
41. Chowdhary, P.K., Keshavan, N., Nguyen, H.Q., Peterson, J.A., Gonzalez, J.E., Haines, D.C., Bacillus megaterium CYP102A1 oxidation of acyl homoserine lactones and acyl homoserines. Biochemistry 46 (2007), 14429–14437.
42. Ciprandi, A., da Silva, W.M., Valadares Santos, A.V., Pimenta, A.M.C., Carepo, M.S.P., Schneider, M.P.C., et al. Chromobacterium violaceum: important insights for virulence and biotechnological potential by exoproteomic studies. Curr. Microbiol. 67 (2013), 100–106.
43. Cress, B.F., Erkert, K.A., Barquera, B., Koffas, M.A.G., Draft genome sequence of Pseudoalteromonas luteoviolacea strain B (ATCC 29581). Genome Announc., 1, 2013, e00048–13.
44. Dall'Agnol, L.T., Martins, R.N., Vallinoto, A.C., Ribeiro, K.T., Diversity of Chromobacterium violaceum isolates from aquatic environments of state of Pará, Brazilian Amazon. Mem. Inst. Oswaldo Cruz 103 (2008), 678–682.
45. Damte, D., Gebru, E., Lee, S.-J., Suh, J.-W., Park, S.-C., Evaluation of anti-quorum sensing activity of 97 indigenous plant extracts from Korea through bioreporter bacterial strains Chromobacterium violaceum and Pseudomonas aeruginosa. J. Microb. Biochem. Technol. 5 (2003), 42–46.
46. Dang, H.T., Yotsumoto, K., Enomoto, K., Draft genome sequence of violacein-producing marine bacterium Pseudoalteromonas sp. 520P1. Genome Announc., 2, 2014, e0134614.
47. Dantas, C., Volpe, L.O., Durán, N., Ferreira, M.M.C., The violacein biosyntheisis monitored by multi-wavelength fluorescence spectroscopy and by the PATRAFAC method. J. Braz. Chem. Soc. 23 (2012), 2054–2064.
48. De Carvalho, D.D., Costa, F.T., Durán, N., Haun, M., Cytotoxic activity of violacein in human colon cancer cells. Toxicol. In Vitro 20 (2006), 1514–1521.
49. De Moss, R.D., Violacein. Antibiotics 2 (1967), 77–81.
50. De Moss, R.D., Happel, M.E., Nutritional requirements of Chromobacterium violaceum. J. Bacteriol. 7 (1959), 137–141.
51. Dobretsov, S., Teplitski, M., Bayer, M., Gunasekera, S., Proksch, P., Paul, V.J., Inhibition of marine biofouling by bacterial quorum sensing inhibitors. Biofouling 27 (2011), 893–905.
52. Domanska, U.M., Kruizinga, R.C., Nagengast, W.B., Timmer-Bosscha, H., Huls, G., de Vries, E.G., et al. A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur. J. Cancer 49 (2013), 219–230.
53. Dong, Y.-H., Xu, J.-L., Li, X.-C., Zhang, L.-H., AiiA, a novel enzyme inactivates acyl homoserine-lactone quorum-sensing signal and attenuates the virulence of Erwinia carotovora. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 3526–3531.
54. Dong, Y.H., Zhang, L.H., Quorum sensing and quorum-quenching enzymes. J. Microbiol. 43 (2005), 101–109.
55. Durán, N., Justo, G.Z., Ferreira, C.V., Melo, P.S., Cordi, L., Martins, D., Violacein: properties and biological activities. Biotechnol. Appl. Biochem. 48 (2007), 127–133.
56. Durán, N., Antonio, R.V., Haun, M., Pilli, R.A., Biosynhtesis of a trypanocide by Chromobacterium violaceum. World J. Microbiol. Biotechnol. 10 (1994), 686–690.
57. Durán, N., Menck, C.F.M., Chromobacterium violaceum: a review of pharmacological and industrial perspectives. Crit. Rev. Microbiol. 27 (2001), 201–222.
58. Durán, M., Ponezi, A.N., Faljoni-Alario, A., Teixeira, M.F.S., Justo, G.Z., Durán, N., Potential applications of violaceína: a microbial pigment. Med. Chem. Res. 21 (2012), 1524–1532.
59. Durán, M., Faljoni-Alario, A., Durán, N., Chromobacterium violaceum and its important metabolites – review. Folia Microbiol. 55 (2010), 535–547.
60. Fang, M.-Y., Zhang, C., Yang, S., Cui, J.-Y., Jiang, P.-X., Lou, K., et al. High crude violacein production from glucose by Escherichia coli engineered with interactive control of tryptophan pathway and violacein biosynthetic pathway. Microb. Cell Factories, 14, 2015, 8.
61. Ferreira, C.V., Bos, C.L., Versteeg, H.H., Justo, G.Z., Durán, N., Peppelenbosch, M.P., Molecular mechanism of violacein-mediated human leukemia cell death. Blood 104 (2004), 1459–1464.
62. Gallardo, M.J., Staforelli, J.P., Meza, P., Bordeu, I., Torres, S., Characterization of Chromobacterium violaceum pigment through a hyperspectral imaging system. AMB Express, 4, 2014, 4.
63. Hagiya, H., Murase,T., Suzuki, M., Shibayama, K., Kokumai, Y., Watanabe, N., et al., 2014. Chromobacterium violaceum nosocomial pneumonia in two Japanese patients at an intensive care unit. J. Infect. Chemother. 20, 139–142.
64. Hakvag, S., Fjærvik, E., Klinkenberg, G., Borgod, S.E.F., Josefsen, K.D., Ellingsen, T.E., et al. Violacein-producing Collimonas sp. from the sea surface microlayer of costal waters in Trøndelag, Norway. Mar. Drugs 7 (2009), 576–688.
65. Harrison, J., Ronczka, J., An extraction of the violacein sequence from pJP101 for expression and analysis in pHSG398. J. Innov. Impact 6 (2013), 24–37.
66. Hashimi, S.M., Xu, T., Wei, M.Q., Violacein anticancer activity is enhanced under hypoxia. Oncol. Rep. 33 (2015), 1731–1736.
67. Hirano, H., Asamizu, S., Onaka, H., Shiro, Y., Nagano, S., Crystal structure of VioE, a key player in the construction of the molecular skeleton of violacein. J. Biol. Chem. 283 (2008), 6459–6466.
68. Hornung, C., Poehlein, A., Haack, F.S., Schmidt, M., Dierking, K., Pohlen, A., et al. The Janthinobacterium sp. HH01 genome encodes a homologue of the V. cholerae CqsA and L. pneumophila LqsA autoinducer synthases. PLoS One, 8, 2013, e55045.
69. Hoshino, T., Violacein and related tryptophanmetabolites produced by Chromobacterium violaceum: biosynthetic mechanism and pathway for construction of violacein core. Appl. Microbiol. Biotechnol. 91 (2011), 1463–1475.
70. Hoshino, T., Hayashi, T., Uchiyama, T., Pseudodeoxyviolacein, a new red pigment produced by the tryptophan metabolism of Chromobacterium violaceum. Biosci. Biotechnol. Biochem. 58 (1994), 279–282.
71. Hungria, M., Astolfi-Filho, S., Chueire, L.M., Nicolás, M.F., Santos, E.B., Bulbol, M.R., et al. Genetic characterization of Chromobacterium isolates from black water environments in the Brazilian Amazon. Lett. Appl. Microbiol. 41 (2005), 17–23.
72. Jiang, P.-X., Wang, H.-S., Zhang, C., Lou, K., Xing, X.-H., Reconstruction of the violacein biosynthetic pathway from Duganella sp. B2 in different heterologous hosts. Appl. Microbiol. Biotechnol. 86 (2010), 1077–1088.
73. Kallmayer, V., Lanzendoerfer, G., Meiring, U., Mocigemba, N., Riedel, H., Schaefer, J., et al. Cosmetic preparations containing violacein as dye. Ger Offen DE, 102005051869, 2007 (A1).
74. Kamaeva, A.A., Vasilchenko, A.S., Deryabin, D.G., Atomic force microscopy reveals a morphological differentiation of Chromobacterium violaceum cells associated with biofilm development and directed by N-hexanoyl-l-homoserine lactone. PLoS ONE, 9, 2014, e103741.
75. Kar, H., Mane, V., Urhekar, A.D., Pachpute, S., Hodiwala, A., Samant, S., et al. A first case report in tertiary care hospital, Navi Mumbai, India – Chromobacterium violaceum septicaemia in a child. Int. J. Curr. Microbiol. Appl. Sci. 2 (2013), 245–249.
76. Karthik, R., Pancharatnam, P., Balaji, V., Fatal Chromobacterium violaceum septicemia in a South Indian adult. J. Infect. Dev. Ctries. 6 (2012), 751–755.
77. Ke, L., An, K.P., Heng, S., Riley, M., Sona, S., Moore, C.E., et al. Paediatric Chromobacterium violaceum in Cambodia: the first documented case. Trop. Dr. 42 (2012), 178–179.
78. Kim, M.H., Choi, W.C., Kang, H.O., Lee, J.S., Kang, B.S., Kim, K.J., et al. The molecular structure and catalytic mechanism of a quorum-quenching N-acyl-L-homoserine lactone hydrolase. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 17606–17611.
79. Kimbrough, T.G., Miller, S.I., Assembly of the type III secretion needle complex of Salmonella typhimurium. Microbes Infect. 4 (2002), 75–82.
80. Konzen, M., De Marco, D., Cordova, C.A., Vieira, T.O., Antônio, R.V., Creczynski-Pasa, T.B., Antioxidant properties of violacein: possible relation on its biological function. Bioorg. Med. Chem. 14 (2006), 8307–8313.
81. Kumar, N.V., Murthy, P.S., Manjunatha, J.R., Bettadaiah, B.K., Synthesis and quorum sensing inhibitory activity of key phenolic compounds of ginger and their derivatives. Food Chem. 159 (2014), 451–457.
82. Kumar, M.R., Chromobacterium violaceum: a rare bacterium isolated from a wound over the scalp. Int. J. Appl. Basic Med. Res. 2 (2012), 70–72.
83. Laatsch, H., Thomson, R.H., Spectroscopic properties of violacein and related compound: crystal structure of tetramethylviolacein. J. Chem. Soc., Perkin Trans. 2, 1984, 1331–1339.
84. Lazdunski, A.M., Ventre, I., Sturgis, J.N., Regulatory circuits and communication in gram-negative bacteria. Nat. Rev. Microbiol. 2 (2004), 581–592.
85. Leal, A.M., de Queiroz, J.D., de Medeiros, S.R., Lima, T.K., Agnez-Lima, L.F., Violacein induces cell death by triggering mitochondrial membrane hyperpolarization in vitro. BMC Microbiol., 15, 2015, 115.
86. Leon, L.L., Miranda, C.C., De Souza, A.O., Durán, N., Antileishmanial activity of the violacein extracted from Chromobacterium violaceum. J. Antimicrob. Chemother. 48 (2001), 449–450.
87. Li, W.J., Zhang, Y., Park, D.J., Li, C.T., Xu, L.H., Kim, C.J., et al. Duganella violaceinigra sp. nov., a novel mesophilic bacterium isolated from forest soil. Inter. J. Syst. Evol. Microbiol. 54 (2004), 1811–1814.
88. Lin, Y.H., Xu, J.L., Hu, J., Wang, L.H., Ong, S.L., Leadbetter, J.R., et al. Acyl-homoserine lactone acylase from Ralstonia strain XJ12B represents a novel and potent class of quorum-quenching enzymes. Mol. Microbiol. 47 (2003), 849–860.
89. Liu, D.X., Didier, P.J., Plauche, G.B., Chromobacterium violaceum infections in 13 non-human primates. J. Med. Primatol. 41 (2012), 107–114.
90. Liu, Z., Wang, W., Zhu, Y., Gong, Q., Yu, W., Lu, X., Antibiotics at subinhibitory concentrations improve the quorum sensing behavior of Chromobacterium violaceum. FEMS Microbiol. Lett. 341 (2013), 37–44.
91. Lopes, S.C., Blanco, Y.C., Justo, G.Z., Nogueira, P.A., Rodrigues, F.L., Goelnitz, U., et al. Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo. Antimicrob. Agents Chemother. 53 (2009), 2149–2152.
92. Lowe, C.A., Asghar, A.H., Shalom, G., Shaw, J.G., Thomas, M.S., The Burkholderia cepacia fur gene: co-localization with omlA and absence of regulation by iron. Microbiology 147 (2001), 1303–1314.
93. Lu, Y., Wang, L., Xue, Y., Zhang, C., Xing, X.-H., Lou, K., et al. Production of violet pigment by a newly isolated psychrotrophic bacterium from a glacier in Xinjiang, China. Biochem. Eng. J. 43 (2009), 135–141.
94. Ma, T., Shi, W., Cheng, J., Zhang, J.-K., Hu, L.-F., Ye, Y., et al. Chromobacterium violaceum infection in China: three case reports and literature reviews. Afr. J. Microbiol. Res. 5 (2011), 3096–3102.
95. McCarthy, S.A., Johnson, R.M., Kakimoto, D., Sakata, T., Effects of various agents on the pigment (violacein) and antibiotic production of Alteromonas luteoviolacein. Nippon Suisan Gakkaishi (Bull. Jpn. Soc. Sci. Fish.) 51 (1985), 1115–1121.
96. McClean, K.H., Winson, M.K., Fish, L., Taylor, A., Chhabra, S.R., Camara, M., et al. Quorum sensing and Chromobacterium violaceum: exploitation of violacein production and inhibition for the detection of N-acyl homoserine lactones. Microbiology 143 (1997), 3703–3711.
97. March, J.C., Bentley, W.R., Quorum sensing and bacterial cross-talk in biotechnology. Curr. Opinion Biotechnol. 15 (2004), 495–502.
98. Martins, D., Frungillo, L., Anazzetti, M.C., Melo, P.S., Durán, N., Antitumoral activity of L-ascorbic acid-poly-D,L-(lactide-co-glycolide) nanoparticles containing violacein. Int. J. Nanomedicine 5 (2010), 77–85.
99. Matz, C., Deines, P., Boenigk, J., Arndt, H., Eberl, L., Kjelleberg, S., et al. Impact of violacein-producing bacteria on survival and feeding of bacterivorous nanoflagellates. Appl. Environ. Microbiol. 70 (2004), 593–599.
100. Matz, C., Webb, J.S., Schupp, P.J., Phang, S.Y., Penesyan, A., Egan, S., et al. Marine biofilm bacteria evade eukaryotic predation by targeted chemical defense. PLoS One, 3, 2008, e2744.
101. Mehta, T., Vercruysse, K., Johnson, T., Ejiofor, A.O., Myles, E., Quick, Q.A., Violacein induces p44/42 mitogen-activated protein kinase-mediated solid tumor cell death and inhibits tumor cell migration. Mol. Med. Rep. 12 (2015), 1443–1448.
102. Menezes, C.B., Silva, B.P., Sousa, I.M., Ruiz, A.L., Spindola, H.M., Cabral, E., et al. In vitro and in vivo antitumor activity of crude extracts obtained from Brazilian Chromobacterium sp isolates. Braz. J. Med. Biol. Res. 46 (2013), 65–70.
103. Mendes, A.S., De Carvalho, J.E., Duarte, M.C.T., Durán, N., Bruns, R.E., 2001b. Optimized production process of violacein and deoxyviolacein by Chromobacterium violaceum by factorial design and response surface methodology. Brazilian Patent PIBr 0100199-0.
104. Mendes, A.S., de Carvalho, J.E., Duarte, M.C.T., Durán, N., Bruns, R.E., Factorial design and response surface optimization of crude violacein for Chromobacterium violaceum production. Biotechnol. Lett. 23 (2001), 1963–1969.
105. Merlin, C., Beaver, L.E., Taylor, O.R., Wolfe, A.A., Repper, S.M., Efficient targeted mutagenesis in the monarch butterfly using zinc-finger nucleases. Genome Res. 23 (2013), 159–168.
106. Miki, T., Akiba, K., Iguchi, M., Danbara, H., Okada, N., The Chromobacterium violaceum type III effector CopE, a guanine nucleotide exchange factor for Rac1 and Cdc42, is involved in bacterial invasion of epithelial cells and pathogenesis. Mol. Microbiol. 80 (2011), 1186–1203.
107. Morohoshi, T., Kato, M., Fukamachi, K., Kato, N., Ikeda, T., N-acyl homoserine lactone regulates violacein production in Chromobacterium violaceum type strain ATCC12472. FEMS Microbiol. Lett. 279 (2008), 124–130.
108. Morohoshi, T., Fukamachi, K., Kato, M., Kato, N., Ikeda, T., Regulation of the violacein biosynthetic gene cluster by acylhomoserine lactone-mediated quorum sensing in Chromobacterium violaceum ATCC 12472. Biosci. Biotechnol. Biochem. 74 (2010), 2116–2119.
109. Moss, M.O., Ryall, C., Logan, N.A., The classification and characterization of chromobacteria from a lowland river. J. Gen. Microbiol. 105 (1978), 11–21.
110. Musthafa, K.S., Ravi, A.V., Annapoorani, A., Packiavathy, I.S., Pandian, S.K., Evaluation of anti-quorum-sensing activity of edible plants and fruits through inhibition of the N-acyl-homoserine lactone system in Chromobacterium violaceum and Pseudomonas aeruginosa. Chemotherapy 56 (2016), 333–339.
111. Nakamura, Y., Sawada, T., Morita, Y., Tamiya, E., Isolation of a psychrotrophic bacterium from the organic residue of a water tank keeping rainbow trout and antibacterial effect of violet pigment produced from the strain. Biochem. Eng. J. 12 (2002), 79–86.
112. Nakamura, Y., Asada, C., Sawada, T., Production of antibacterial violet pigment by psychrotropic bacterium RT102 strain. Biotechnol. Bioproc. Eng. 8 (2003), 37–40.
113. Ochsner, U.A., Vasil, A.I., Johnson, Z., Vasil, M.L., Pseudomonas aeruginosa fur overlaps with a gene encoding a novel outer membrane lipoprotein, OmlA. J. Bacteriol. 181 (1999), 1099–1109.
114. Onaka, H., Biosynthesis of indolocarbaxole and goadsporin, two different heterocyclic antibiotics produced by actinomycetes. Biosci. Biotechnol. Biochem. 73 (2009), 2149–2155.
115. Orsetti, A.G., Markiewicz, P., Epstein, M.G., Conceicao, O.J.G., D'Ippolito, G., Ribeiro, M.A.F., Liver abscesses by Chromobacterium violaceum: a case report of a rare disease. OA Case Rep., 2, 2013, 19.
116. Pantanella, F., Berlutti, F., Passariello, C., Sarli, S., Morea, C., Schippa, S., Violacein and biofilm production in Janthinobacterium lividum. J. Appl. Microbiol. 102 (2007), 992–999.
117. Pellegrini, M.C., Alvarez, V., Ponce, A.G., Cugnata, N.M., De Piano, F.G., Fuselli, S.R., Anti-quorum sensing and antimicrobial activity of aromatic species from South America. J. Essent. Oil Res. 26 (2014), 458–465.
118. Platt, D., Amara, S., Mehta, T., Vercuyssee, K., Myles, E.L., Johnson, T., et al. Violacein inhibits matrix metalloproteinase mediated CXCR4 expression: potential anti-tumor effect in cancer invasion and metastasis. Biochem. Biophys. Res. Commun. 455 (2014), 107–112.
119. Queiroz, K.C., Milani, R., Ruela-de-Sousa, R.R., Fuhler, G.M., Justo, G.Z., Zambuzzi, W.F., et al. Violacein induces death of resistant leukaemia cells via kinome reprogramming, endoplasmic reticulum stress and Golgi apparatus collapse. PLoS One, 7, 2012, e45362.
120. Rahul, S., Chandrashekhar, P., Hemant, B., Bipinchandra, S., Mouray, E., Grellier, P., et al. In vitro antiparasitic activity of microbial pigments and their combination with phytosynthesized metal nanoparticles. Parasitol. Int. 64 (2015), 353–356.
121. Rai, R., Karnaker, V.K., Shetty, V., Krishnaprasad, M.S., Chromobacterium violaceum septicaemia-a case report. Al Ameen J. Med. Sci. 4 (2011), 201–203.
122. Rajalakshmi, G., Sankaravadivoo, A., Prabhakaran, S., Characterization of Chromobacterium violaceum isolated from spoiled vegetables and antibiogram of violacein. J. Adv. Lab. Res. Biol. 1 (2011), 22–27.
123. Ran, T., Gao, M., Wei, Q., He, J., Tang, L., Wang, W., et al. Expression, crystallization and preliminary crystallographic data analysis of VioD, a hydroxylase in the violacein-biosynthesis pathway. Acta Cryst F71 (2015), 149–152.
124. Rashid, Z., Ali, U., Sulong, A., Rahman, R., Chromobacterium violaceum infections; a series of case reports in a Malaysian tertiary hospital. Internet J. Infect. Dis., 11, 2013, 1.
125. Rettori, D., Durán, N., 1997. Stationary tray bioreactor for the bacterial metabolite production. Brazilian Patent PIBr 9702986–6.
126. Rettori, D., Durán, N., Production, extraction and purification of violacein: an antibiotic pigment produced by Chromobacterium violaceum. World J. Microbiol. Biotechnol. 14 (1998), 685–688.
127. Rettori, D., Rodriguez, R.A., Durán, N., Chromobacterium violaceum under oxidative stress. Rev. Farm. Bioquim. Univ. São Paulo, 34(Suppl. 1), 1998, 169.
128. Riveros, R., Haun, M., Durán, N., Bacterial chemistry-V: effect of growth conditions on production of violacein by Chromobacterium violaceum BB-78 strain. Braz. J. Med. Biol. Res. 22 (1989), 569–577.
129. Rodrigues, A.L., Trachtmann, N., Becker, J., Lohanatha, A.F., Blotenberg, J., Bolten, C.J., et al. Systems metabolic engineering of Escherichia coli for production of the antitumor drugs violacein and deoxyviolacein. Metab. Eng. 20 (2013), 29–41.
130. Rodrigues, A.L., Goecke, Y., Bolten, C., Brock, N.L., Dickschat, J.S., Wittmann, C., Microbial production of the drugs violacein and deoxyviolacein: analytical development and strain comparison. Biotechnol. Lett. 34 (2012), 717–720.
131. Rucinsky, T.E., Cota-Robles, E.H., Mesosome structure in Chromobacterium violaceum. J. Bacteriol. 118 (1974), 717–724.
132. Ryan, K.S., Balibar, C.J., Turo, K.E., Walsh, C.T., Drennan, C.L., The violacein biosynthetic enzyme VioE shares a fold with lipoprotein transporter proteins. J. Biol. Chem. 283 (2008), 6467–6475.
133. Sánchez, C., Braña, A.F., Méndez, C., Salas, J.A., Reevaluation of the violacein biosynthetic pathway and its relationship to indolocarbazole biosynthesis. Chembiochem 7 (2006), 1231–1240.
134. Sawipak, S., Wichai, S., The study of bacteria producing bluish-purple pigment and use for cotton dyeing. Proceedings of the 33rd Congress on Science and Technology of Thailand. October 18–20, 2007, Nakhon Si Thammarat. Thailand 33 (2007), 1–2.
135. Schaefer, A.L., Greenberg, E.P., Oliver, C.M., Oda, Y., Huang, J.J., Bittan-Banin, G., et al. A new class of homoserine lactone quorum-sensing signals. Nature 454 (2008), 595–599.
136. Scheelings, T.S., Tesdorpf, R., Hooper, C., Stalder, K., Chromobacterium violaceum isolation from a Macquarie turtle (Emydura macquarii). J. Herpetol. Med. Surg. 22 (2012), 22–24.
137. Seigel, J.K., Stadler, M.E., Lombrano, J.L., Almony, J.S., Couch, M.E., Belhorn, T.H., Chromobacterium violaceum necrotizing fasciitis: a case report and review of the literature. Ear Nose Throat 91 (2012), 479–483.
138. Shinoda, K., Hasegawa, T., Sato, H., Shinozaki, M., Kuramot, H., Takamiya, Y., et al. Biosynthesis of violacein: a genuine intermediate, protoviolaceinic acid, produced by VioABDE, and insight into VioC function. Chem. Commun. (Camb). 40 (2007), 4140–4142.
139. Shirata, A., Tsukamoto, T., Kato, H., Hata, T., Yasui, T., Kojima, A., Blue purple pigment manufacture with microorganism and applications of the pigment. Jpn. Kokai Tokkyo Koho JP, 1998, 10113169 (A0).
140. Soliev, A.B., Hosokawa, K., Enomoto, K., Bioactive pigments frommarine bacteria: applications and physiological roles. Evidence-Based Complem. Altern. Med., 2011, 670349 (2011).
141. Stauff, D.L., Bassler, B.L., Quorum sensing in Chromobacterium violaceum: DNA recognition and gene regulation by the CviR receptor. J. Bacteriol. 193 (2011), 3871–3878.
142. Suryawanshi, R.K., Patil, C.D., Borase, H.P., Narkhede, C.P., Stevenson, A., Hallsworth, J.E., et al. Towards an understanding of bacterial metabolites prodigiosin and violacein and their potential for use in commercial sunscreens. Intern. J. Cosm. Sci. 37 (2015), 98–107.
143. Subramaniam, S., Ravi, V., Sivasubramanian, A., Synergistic antimicrobial profiling of violacein with commercial antibiotics against pathogenic micro-organisms. Pharm. Biol. 52 (2014), 86–90.
144. Swain, B., Otta, S., Sahu, K.K., Panda, K., Rout, S., Urinary tract infection by Chromobacterium violaceum. J. Clin. Diagn. Res. 8 (2014), DD01–DD02.
145. Swem, L.R., Swem, D.L., O'Loughlin, C.T., Gatmaitan, R., Zhao, B., Ulrich, S.M., et al. A quorum-sensing antagonist targets both membrane-bound and cytoplasmic receptors and controls bacterial pathogenicity. Mol. Cell 35 (2009), 143–153.
146. Tan, T.O., Montforts, F.P., Meyer, D., Microbiological method for the biosynthesis of natural blue-violet colorants violacein and desoxyviolacein. PCT Int. Appl. WO, 2002, 2002050299 (A2).
147. Tan, T.O., Mantfors, F-P., Meyer, D., 2011. Microbiological method of the biosynthesis of natural blue-violet colorants violacein and deoxyviolacein and the utilization thereof. US Patent. US7901914.
148. Teasdale, M.E., Liu, J., Wallace, J., Akhlaghi, F., Rowley, D.C., Secondary metabolites produced by the marine bacterium Halobacillus salinus that inhibit quorum sensing-controlled phenotypes in Gram-negative bacteria. Appl. Environ. Microbiol. 75 (2009), 567–572.
149. Thomas, T., Evans, F.F., Schleheck, D., Mai-Prochnow, A., Burke, C., Penesyan, A., et al. Analysis of the Pseudoalteromonas tunicate genome reveals properties of a surface-associated life style in the marine environment. PLoS One, 3, 2008, e3252.
150. Tobie, W.C., The pigment of Bacillus violaceus I. The production, extraction, and purification of violacein. J. Bacteriol. 29 (1934), 223–227.
151. Tyler, B.M., Molecular basis of recognition between phytophthora pathogens and their hosts. Annu. Rev. Phytopathol. 40 (2002), 137–167.
152. Umadevi, S., Kumar, S., Stephen, S., Joseph, N.M., Chromobacterium violaceum: a potential nosocomial pathogen. Am. J. Infect. Control 41 (2013), 386–388.
153. Unnerstad, H.E., Lindberg, A., Waler, K.P., Ekman, T., Artursson, K., Nilssn-Ost, M., et al. Microbial aetiology of acute clinical mastitis and agent-specific risk factors. Vet. Microbiol. 137 (2009), 90–97.
154. Uroz, S., Chhabra, S.R., Camara, M., Williams, P., Oger, P., Dessaux, Y., N-acyl-homoserine lactone quorum-sensing molecules are modified and degraded by Rhodococcus erythropolis W2 by both amidolytic and novel oxidoreductase activities. Microbiology 151 (2005), 3313–3322.
155. Valastyan, S., Weinberg, R.A., Tumor metastasis: molecular insights and evolving paradigms. Cell 147 (2011), 275–292.
156. Venil, C.K., Zakaria, Z.A., Ahmad, W.A., Bacterial pigments and their applications. Process Biochem. 48 (2013), 1065–1079.
157. Venil, C.K., Aruldass, C.A., Halim, M.H.A., Khasim, A.R., Zakaria, Z.A., Ahmad, W.A., Spray drying of violet pigment from Chromobacterium violaceum UTM5 and its application in food model systems. Inter. Biodeter. Biodegrad. 102 (2015), 324–329.
158. Verinaud, L., Lopes, S.C., Prado, I.C., Zanucoli, F., Alves da Costa, T., Di Gangi, R., et al. Violacein treatment modulates acute and chronic inflammation through the suppression of cytokine production and induction of regulatory T cells. PLoS One, 10, 2015, e0125409.
159. Wang, H.S., Wang, F.Z., Zhu, X.F., Yan, Y.C., Yu, X.H., Jiang, P.X., et al. Biosynthesis and characterization of violacein, deoxyviolacein and oxyviolacein in heterologous host, and their antimicrobial activities. Biochem. Eng. J. 67 (2012), 148–155.
160. Wang, H.S., Jiang, P.X., Lu, Y., Ruan, Z., Jiang, R., Lou, K., et al. Optimization of culture conditions for violacein production by a new strain of Duganella sp. B2. Biochem. Eng. J. 44 (2009), 119–124.
161. Wang, Y., Ikawa, A., Okaue, S., Taniguchi, S., Osaka, I., Yoshimoto, A., et al. Quorum sensing signaling molecules involved in the production of violacein by Pseudoalteromonas. Biosci. Biotechnol. Biochem. 72 (2008), 1958–1961.
162. Yada, S., Wang, Y., Zou, Y., Nagasaki, K., Hosokawa, K., Osaka, I., et al. Isolation and characterization of two groups of novel marine bacteria producing violacein. Mar. Biotechnol. 10 (2008), 128–132.
163. Yang, C.H., Li, Y.H., Chromobacterium violaceum infection: a clinical review of an important but neglected infection. J. Chin. Med. Assoc. 74 (2011), 435–441.
164. Yang, L.H., Xiong, H., Lee, O.O., Qi, S.-H., Qian, P.-Y., Effect of agitation on violacein production in Pseudoalteromonas luteoviolacea isolated from a marine sponge. Lett. Appl. Microbiol. 44 (2007), 625–630.
165. Yang, C., Jiang, P., Xiao, S., Zhang, C., Lou, K., Xing, X.-H., Fed-batch fermentation of recombinant Citrobacter freundii with expression of a violacein-synthesizing gene cluster for efficient violacein production from glycerol. Biochem. Eng. J. 57 (2011), 55–62.
166. Zhang, X., Enomoto, K., Characterization of a gene cluster and its putative promoter region for violacein biosynthesis in Pseudoalteromonas sp. 520P1. Appl. Microbiol. Biotechnol. 90 (2011), 1963–1971.
167. Zhao, M., Yu, Y., Hua, Y., Feng, F., Tong, Y., Yang, X., et al. Design, synthesis and biological evaluation of N-sulfonyl homoserine lactone derivatives as inhibitors of quorum sensing in Chromobacterium violaceum. Molecules 18 (2013), 3266–3278.
168. Zhou, L., Zheng, H., Tang, Y., Yu, W., Gong, Q., Eugenol inhibits quorum sensing at sub-inhibitory concentrations. Biotechnol. Lett. 35 (2013), 631–637.